Markets:

Overview

News

Currencies

International

Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

13.39 +0.44 (+3.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

34 35 Next >

Psychedelic Stock Gainers And Losers From November 21, 2022 ↗

November 21, 2022

Via Benzinga

Psychedelic Drug Stocks Index Continued To Decline Last Week ↗

November 20, 2022

This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...

Via Talk Markets

Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

November 18, 2022

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 17, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 16, 2022 ↗

November 16, 2022

Via Benzinga

GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 15, 2022

Via Benzinga

Mind Medicine’s Bad Trip Won’t End Anytime Soon ↗

November 04, 2022

Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 ↗

November 16, 2022

Upgrades

Via Benzinga

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗

November 15, 2022

Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

Via Benzinga

Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls

November 14, 2022

From Concerned Shareholders of Company MindMed

Via GlobeNewswire

Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗

November 14, 2022

We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...

Via Talk Markets

MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials ↗

November 11, 2022

Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022.

Via Benzinga

Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗

November 10, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05

Via Benzinga

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 09, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From November 8, 2022 ↗

November 08, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14

Via Benzinga

The Psychedelic Drug Stocks Index Continued To Plummet Last Week ↗

November 07, 2022

In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.

Via Talk Markets

Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗

November 07, 2022

GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44

Via Benzinga

Psychedelic Stock Gainers And Losers From November 3, 2022 ↗

November 03, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27

Via Benzinga

Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S. ↗

November 03, 2022

Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...

Via Benzinga

Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct

November 03, 2022

From Concerned Shareholders of Company MindMed

Via GlobeNewswire

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

November 02, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:

Via Benzinga

7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov. ↗

October 28, 2022

While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities.

Via InvestorPlace

October Recap: Major Psychedelic Drug Stocks Declined 9.9% ↗

October 27, 2022

In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.

Via Talk Markets

Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 27, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87

Via Benzinga

Psychedelic Stock Gainers And Losers From October 26, 2022 ↗

October 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18

Via Benzinga

Psychedelic Stock Gainers And Losers From October 25, 2022 ↗

October 25, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39

Via Benzinga

Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week ↗

October 24, 2022

The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since...

Via Talk Markets

Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 21, 2022

GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53

Via Benzinga

Why Mind Medicine Zoomed 8% Higher on Tuesday ↗

October 18, 2022

The support for legalizing drugs -- such as those being studied by the company -- grows with a U.S. senator's tweet.

Via The Motley Fool

Psychedelic Stock Gainers And Losers From October 18, 2022 ↗

October 18, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.